HSF4 and early-onset non-syndromic cataract: These results suggest that direct screening HSF4 mutations with one pair of primers, co-segregation and bioinformatics analyses, and mutation evaluation based on ACMG guidelines, might be a cost-effective, comprehensive and reliable method for molecular diagnosis of congenital cataracts.